Informe del mercado de fraccionamiento de plasma por producto (inmunoglobulinas, albúmina, factor de coagulación VIII, factor de coagulación IX), sector (sector privado, sector público), aplicación (neurología, inmunología, hematología y otros), usuario final (hospitales y clínicas, laboratorios de investigación clínica, institutos académicos) y región 2024-2032

Informe del mercado de fraccionamiento de plasma por producto (inmunoglobulinas, albúmina, factor de coagulación VIII, factor de coagulación IX), sector (sector privado, sector público), aplicación (neurología, inmunología, hematología y otros), usuario final (hospitales y clínicas, laboratorios de investigación clínica, institutos académicos) y región 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A18245

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Plasma Fractionation Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Immunoglobulins
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Albumin
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Coagulation factor VIII
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Coagulation factor IX
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Sector
    7.1    Private Sector
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Public Sector
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Application
    8.1    Neurology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Immunology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Hematology
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Other Applications
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Clinical Research Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Academic Institutes
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    ADMA Biologics
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Bio Products Laboratory Ltd.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Boccard
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Grifols, S.A.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Hemarus Therapeutics Limited
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Intas Pharmaceuticals Limited
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    LFB S.A.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Merck Group
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Octapharma AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 SWOT Analysis
        15.3.10    PlasmaGen BioSciences Pvt. Ltd.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    SK Plasma Co. Ltd.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
        15.3.12    Virchow Biotech Private Limited
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio

Informe del mercado de fraccionamiento de plasma por producto (inmunoglobulinas, albúmina, factor de coagulación VIII, factor de coagulación IX), sector (sector privado, sector público), aplicación (neurología, inmunología, hematología y otros), usuario final (hospitales y clínicas, laboratorios de investigación clínica, institutos académicos) y región 2024-2032
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials